# Imaging with [89Zr]Panitumumab-PET/MRI in Patients with Newly Diagnosed Colorectal Cancer

> **NCT03764137** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **University of Alabama at Birmingham**

## Conditions studied

- Metastatic Colon Cancer

## Interventions

- **DRUG:** [89Zr]Panitumumab PET-MRI

## Key facts

- **NCT ID:** NCT03764137
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-03-14
- **Primary completion:** 2025-01
- **Final completion:** 2026-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study was not able to enroll any subjects
- **Last updated:** 2025-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03764137

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03764137, "Imaging with [89Zr]Panitumumab-PET/MRI in Patients with Newly Diagnosed Colorectal Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03764137. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*